BiotherapyVideo
Categories
- Allergy
- Alzheimer's Disease
- Arthritis
- Asthma
- Breast Cancer
- Cardio Health
- Cholesterol
- Cold and Flu
- Colon Cancer
- Diabetes
- Dieting
- Epilepsy
- Hair Loss
- Headache
- Heartburn
- HIV & AIDS
- Kidney Health
- Leukemia
- Lung Cancer
- Lymphoma
- Multiple Sclerosis
- Men's Health
- Mental Health
- Nutrition
- Osteoporosis
- Parkinson's Disease
- Prostate Health
- Skin Health
- Sleep Disorders
- Women's Health
- General
Researchers Hunt Normal Cells That Give Rise to Cancer
Posted on 08/11/2008, 14:00
By -- Robert Preidt
Identifying these progenitors may provide context for tumor formation, new treatments
MONDAY, Aug. 11 (HealthDay News) -- Learning more about normal cells that give rise to cancer may hold the key to understanding and treating cancer, according to Duke University Medical Center researchers who identified cells linked to a deadly brain cancer.
"Identifying the specific, normal cells that cancer come from can provide critical insight into how cancers develop. This may help us develop more rational and effective approaches to treatment," Robert Wechsler-Reya, an associate professor of pharmacology and cancer biology, said in a medical center news release.
In what's believed to be a first, the Duke team had identified two types of cells in the brain that can give rise to the malignant brain tumor medulloblastoma. It occurs most commonly in children and is treated with a combination of surgery, chemotherapy and radiation, which cause severe side effects.
In order to identify the normal cells associated with medulloblastoma, the Duke researchers and colleagues in Australia created mouse models of medulloblastoma by turning off the patched gene, an important regulator of cell growth in the cerebellum. Specifically, they switched off the patched gene in granule neuron precursors (GNPs), which make one particular type of neuron, or in stem cells, which can make all the different cell types in the cerebellum.
When the patched gene was turned off in GNPs, 100 percent of the mice developed medulloblastoma. When the gene was deleted from stem cells, most of them went on to form normal cell types within the cerebellum.
The findings provide the first definitive proof that medulloblastoma can be triggered in GNPs, the researchers said.
"Simply mutating a gene is not enough to cause cancer. The mutation has to happen in the right cell type at the right time. In the case of patched, GNPs provide the critical context for tumor formation," Wechsler-Reya said.
The study was published in the August issue of the journal Cancer Cell.
More information
The U.S. National Cancer Institute has more about cancer.
SOURCE: Duke University, news release, Aug. 11, 2008
Copyright © 2008 ScoutNews, LLC. All rights reserved.
BigHealthTree.com Disclaimer
Bighealthtree.com Does Not Provide Medical Advice. This site, including the above information, is for informational purposes only and is not a substitute for professional medical or health advice. Always seek the advice of your physician or a qualified health or medical professional before starting any new treatment, changing existing treatment, or altering your current exercise and/or diet program. If you think you are having a medical emergency, call 911 (or the emergency services in your area) or your doctor immediately.
Prenatal Alcohol
Ovarian Cancer
Fire Safe Cigarettes
Christmas Colonoscopy
ER Doctors
Colonoscopy Study
Carbon Monoxide Family
Busting Diet Myths
Holiday Eating
Colon Cancer Race
Yoga and Stress
Fast Food
In the Dark
Sleep Meds

Comments (0):
Be the first to comment on this article.
Post a comment